Outlook Therapeutics (OTLK) Change in Inventory (2024 - 2026)
Outlook Therapeutics (OTLK) posted quarterly Change in Inventory of -$113822.0 for Q1 2026, down 122.99% year-over-year from $495134.0 in Q1 2025, and down 195.12% quarter-over-quarter from $119660.0 in Q4 2025.
Outlook Therapeutics (OTLK) Change in Inventory (2024 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Change in Inventory for 3 consecutive years, with -$113822.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 122.99% year-over-year to -$113822.0; the TTM figure through Mar 2026 stood at -$260289.0 (changed N/A YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
- Change in Inventory eased to -$113822.0 in Q1 2026 per OTLK's latest filing, from $119660.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $3.1 million in Q4 2024 and bottomed at -$788312.0 in Q3 2025.
- Historically, Change in Inventory has averaged $557373.7 across 3 years, with a median of $307397.0 in 2025.
- Annual changes were most pronounced in 2025 — Change in Inventory slumped 96.15% — and 2026, when it tumbled 122.99%.
- Outlook Therapeutics' Change in Inventory stood at $3.1 million in 2024, then plunged by 96.15% to $119660.0 in 2025, then slumped by 195.12% to -$113822.0 in 2026.
- Business Quant data shows OTLK's Change in Inventory at -$113822.0 in Q1 2026, $119660.0 in Q4 2025, and -$788312.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113,822.00 |
| Mar 31, 2026 | -113,822.00 |
| Dec 31, 2025 | 119,660.00 |
| Dec 31, 2025 | 119,660.00 |
| Sep 30, 2025 | -788,312.00 |
| Sep 30, 2025 | -788,312.00 |
| Jun 30, 2025 | 522,185.00 |
| Jun 30, 2025 | 522,185.00 |
| Mar 31, 2025 | 495,134.00 |
| Mar 31, 2025 | 495,134.00 |
| Dec 31, 2024 | 3.11 Mn |
| Dec 31, 2024 | 3.11 Mn |